THE API POWDER DIARIES

“The present condition has exposed some structural weaknesses during the EU’s medicines supply chain along with a higher dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides claimed. She advised that provide chain troubles be tackled in an EU pharmaceutical strategy expected for being released by the